首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Lung cancer management

缩写:

ISSN:1758-1966

e-ISSN:1758-1974

IF/分区:0.9/N/A

文章目录 更多期刊信息

共收录本刊相关文章索引120
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Ryu Kanzaki,Jiro Okami Ryu Kanzaki
Lung cancer and cardiovascular diseases (CVDs) frequently coexist due to shared risk factors such as aging, smoking, and chronic inflammation. The growing prevalence of elderly surgical candidates with concomitant lung cancer and CVDs prese...
Mengmeng Liu,Lu Zhong,Tong Liu Mengmeng Liu
Background: This study evaluated the cost-effectiveness of Tepotinib versus Capmatinib in patients with advanced or metastatic non-small cell lung cancer (NSCLC) with MET Exon 14 Skipping Mutations in China. ...
Jeremy P Harris,Christina Boyd,Mengying Shi et al. Jeremy P Harris et al.
Introduction: Treatment indications for oligometastatic/oligoprogressive lung tumors are growing. Safety and lack of detrimental effect on patients' quality of life are critical for novel local therapies. ...
Tingting Wang,Jingjing Fan,Xiaoyan Lv et al. Tingting Wang et al.
The utilization of pathological assessment to evaluate tumor response in patients with early-stage non-small cell lung cancer (NSCLC) has not been documented in the extant literature. A 64-year-old male patient with lung adenocarcinoma was ...
Bingqi Hu,Jing Xue,Dingsiman Li et al. Bingqi Hu et al.
Aim: To estimate brain metastases (BM) management costs in Chinese ALK+ advanced non-small-cell lung cancer (NSCLC) patients receiving first-line (1 L) ALK tyrosine kinase inhibitors (TKIs). ...
Nasim Nosoudi,Amir Zadeh,Rayna Nichols et al. Nasim Nosoudi et al.
Aims: This study aimed to predict post-transplant malignancy risks at multiple levels among lung transplant recipients using machine learning (ML) and to identify key clinical and immunogenetic predictors. ...
Luigi Cerbone,Benedetta Del Rio,Sara Delfanti et al. Luigi Cerbone et al.
Pleural mesothelioma is a rare disease with few therapeutic options, especially in the first line refractory setting. Targeted agents did not demonstrate a significant clinical benefit in mesothelioma treatment, nevertheless a small group o...
Ninghuang Dai,Chen Fang,Yu Gu et al. Ninghuang Dai et al.
Background: Metabolic reprogramming, particularly toward oxidative phosphorylation (OXPHOS), is a hallmark of lung squamous cell carcinoma (LUSC) and contributes to its aggressive phenotype and immunosuppressive microenvi...
Vuong V Do,Eduardo R Núñez,Fatima G Wilder et al. Vuong V Do et al.
Introduction: This study aimed to examine the association between social determinants of health (SDOH) and lung cancer screening (LCS) utilization. Method...
Tianhua Liu,Yizhuo Chen,Ziqing Xu et al. Tianhua Liu et al.
We present the case of a 66-year-old male patient who was found to have a lung nodule during the perioperative period for poorly differentiated carcinoma of the ileocecal region. Subsequent surgical procedures were performed to remove the i...